46998 Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices 

Matters to be Discussed: The meeting will 

convene to address matters related to the 

conduct of Study section business and for the 

study section to consider safety and 

occupational health-related grant 

applications. Agenda items are subject to 

change as priorities dictate. 

Contact Person for More Information: Price 

Connor, PhD, NIOSH Health Scientist, 1600 

Clifton Road, NE., Mailstop E–20, Atlanta, 

Georgia 30333, Telephone (404) 498–2511, 

Fax (404) 498–2571. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 3, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–21991 Filed 9–11–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Public 

Forums 

Notice is hereby given of two forums 

of the working groups of the NIH 

Scientific Management Review Board: 

Deliberating Organizational Changes 

and Effectiveness Working Group and 

Substance Use, Abuse and Addition 

Working Group. The forums will serve 

as the first among a series of sessions for 

gathering information on the agency’s 

organizational structure and 

recommendations for enhancing the 

NIH mission through greater agency 

flexibility and responsiveness. 

The forums will be open to the public, 

with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The input from these meetings will be 

summarized in a report that will be 

presented to the Scientific Management 

Review Board in open session at an 

upcoming meeting. 

Name of Committee: Substance Use, 

Abuse, and Addiction Working Group of the 

Scientific Management Review Board. 

Date: September 23, 2009. 

Open: 8 a.m. to 3 p.m. 

Agenda: Presentation and discussion will 

include an overview of the science of 

substance use, abuse, and addiction and the 

public health needs in this area of research. 

Place: National Institutes of Health, 

Building 60, Chapel and Lecture Hall, 9000 

Rockville Pike, Bethesda, MD 20892. 

Name of Committee: Deliberating 

Organizational Change and Effectiveness 

Working Group of the Scientific Management 

Review Board. 

Date: September 24, 2009. 

Open: 8 a.m. to 3 p.m. 

Agenda: Presentations and discussion will 

include an overview of NIH mission and 

function from scientific and stakeholder 

perspectives, including elaboration upon the 

principles and attributes fundamental to its 

success. 

Place: National Institutes of Health, 

Building 60, Chapel and Lecture Hall, 9000 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Dr. Lyric Jorgenson, PhD, 

NIH–AAAS Science and Technology Policy 

Fellow, Office of Science Policy, Office of the 

Director, NIH, National Institutes of Health, 

Building 1, Room 218, MSC 0166, 9000 

Rockville Pike, Bethesda, MD 20892, 

smrb@mail.nih.gov, (301) 496–6837. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. The 

meeting will also be webcast. The draft 

meeting agenda and other information about 

the SMRB, including information about 

access to the webcast, will be available at 

http://smrb.od.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Dated: August 28, 2009. 

Lynn Hudson, 

Acting Director, Office of Biotechnology 

Activities. 

[FR Doc. E9–22000 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Child Health and Human Development 

Council, September 21, 2009, 8 a.m. to 

September 21, 2009, 5 p.m., National 

Institutes of Health, Building 31, 31 

Center Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on September 1, 2009, 74 FR 

54224. 

This notice is being amended to 

provide additional attendee viewing and 

Videocast access instructions for open 

session of Council. In order to facilitate 

public attendance at the open session of 

Council, reserve seating will be made 

available to the first five individuals 

reserving seats in the main meeting 

room, Conference Room 6. Please 

Contact Ms. Lisa Kaeser, Program and 

Public Liaison Office, NICHD, at 301– 

496–0536 to make your reservation. 

Additional seating will be available in 

the meeting overflow rooms, Conference 

Rooms 7 and 8. Individuals will also be 

able to view the meeting via NIH 

Videocast. Please go to the following 

link for Videocast access instructions at: 

http://www.nichd.nih.gov/about/ 

overview/advisory/nachhd/virtualmeeting-200910.cfm. The meeting is 

partially closed to the public. 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–21998 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0667] 

[FDA 225–09–0010] 

Memorandum of Understanding With 

Duke University 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the Food 

and Drug Administration and Duke 

University. The purpose of this MOU is 

to establish a framework for 

collaboration between the Parties and 

for pursuing specific collaborative 

projects. This collaboration between the 

Parties shall be known as the Cardiac 

Safety Research Consortium. 

DATES: The agreement became effective 

August 4, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Wendy R. Sanhai, Office of the 

Commissioner (HZ–1), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–7867, 

FAX: 301–827–5891. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 


cprice-sewell on DSK2BSOYB1PROD with NOTICES